IABP-SHOCK-2
2012 Cardiology
37 ICUs
600 patients
IABP in ACS with early revascularisation
Clinical Question
In patients with acute MI and cardiogenic shock, does intraaortic balloon counterpulsation (IABP) vs. medical therapy alone improve mortality?
Critical Appraisal
Key findings
No benefit. No increased complications with IABP. High x-over rate
Critique
Non-blinded. High cross over rate.
- Population
- Cardiogenic Shock
- Population Details
- Acute MI with or without STE
- Intervention Arms
-
IABP
Inserted either before or immediately after PCI - Control Arms
-
Standard Care
- Primary Outcome
- 30 day mortality
- Secondary Outcomes
- No difference in mortality
- P Value
- 0.69
Outcome Results
Not recorded
Primary location: Germany
Landmark trial